Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Enoxaparin for Occult Catheter-Related DVT in Children
NCT00633061Phase 2Terminated
- Sponsor
- UT Southwestern Medical Center
- Start
- Jun 2008
- Primary completion
- Jun 2011
- Modality
- Recombinant Proteins and Enzymes
- Countries
- 1
01
Overview
Phase 2, randomised, open-label trial in deep vein thrombosis (DVT) comparing Enoxaparin with Observation (2 arms). Primary endpoint: Composite Endpoint: Catheter Removal, Signs and Symptoms of DVT or PE, or Bacteremia/Fungemia at 16 weeks. Started Jun 2008; status: terminated.
02
Drugs
enoxaparin
03
Conditions
deep vein thrombosis (DVT)
Beyond the preview
Go deeper on NCT00633061.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00633061.